Aug. 14, 2013 | Urology & Urogynecology

LABORIE NAMES BRIAN ELLACOTT AS NEW PRESIDENT AND CEO

Prior to joining LABORIE, Brian served as General Manager of Invacare’s (NYSE:IVC) $1 Billion North and South American businesses. Brian’s previous experience includes leadership roles at American Hospital Supply and Baxter International in Canada, Australia and the United States.

“Through 30 years in healthcare, Brian brings significant global healthcare knowledge and a proven track record in growing businesses and achieving operational excellence in various roles in healthcare manufacturing, distribution and services,” said Jamie Fraser, Executive Chairman of LABORIE. “I look forward to working with Brian as we expand our global leadership position in Urodynamics and other specialized pelvic floor disorders.”

“I am very excited to be part of the LABORIE team and I welcome opportunity to lead LABORIE as we expand our global platform of products and services,” Ellacott stated. “Together with the rest of the LABORIE leadership team I look forward to building on the strong LABORIE brand position and industry leading products to assist patients who suffer from Urology, Gynecology and Colorectal disorders.”

About LABORIE                                                                             

LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading global developer, manufacturer and marketer of innovative medical technology and consumables used for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields.

Share This Article

Featured Articles

LABORIE MEDICAL TECHNOLOGIES AND COGENTIX MEDICAL ANNOUNCE COMPLETION OF ACQUISITION OF COGENTIX MED

LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).

LABORIE MEDICAL TECHNOLOGIES ANNOUNCES SUCCESSFUL COMPLETION OF TENDER OFFER FOR COGENTIX MEDICAL, I

LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)

LABORIE MEDICAL TECHNOLOGIES TO ACQUIRE COGENTIX MEDICAL INC., FOR $214 MILLION

LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)

Subscribe to News